Alzheimer Disease and Dementia

ALZHEIMER DISEASE AND DEMENTIA

Featured Article

Q/A: The Alzheimer’s Association Report: 2021 Alzheimer’s Disease Facts and Figures

We spoke to Carl V Hill, PhD, MPH, chief diversity, equity and inclusion officer of the Alzheimer’s Association about the results of the Alzheimer’s Association report, 2021 Alzheimer’s Disease Facts and Figures.

all features >>

Latest News

Physicians Less Likely to Test for Pulmonary Embolism in Dementia Patients

Findings seen in patients with dementia presenting with clinical factors known to be predictive of pulmonary embolism risk

Levetiracetam Well Tolerated for Alzheimer Disease

For patients with Alzheimer disease, levetiracetam is well tolerated and improves performance on certain cognitive tasks among those with epileptiform activity.

Psychosocial Interventions for Patients With Dementia: Here’s What Works

Mary Stroka

Performing a systematic review, researchers assessed various psychosocial interventions to determine whether they improve cognitive function and quality of life in patients with moderate to severe dementia.

Ophthalmic Conditions Linked to Increased Risk for Dementia

Age-related macular degeneration, diabetes-related eye disease, and cataract are associated with an increased risk for incident dementia.

Hallucinations May Be Charles Bonnet Syndrome, Not Early Dementia

K. Patricia Bouweraerts, MA

In a 10-year follow-up of AREDS 2 participants, symptoms of CBS were associated with late AMD and cataract surgery, but normal cognition.

Man with white cane standing at metro station

Visual Impairment Associated With Elevated Dementia Risk

Vincent Soreca

Visual treatments may provide modifiable risk factor for dementia.

Sustained Response to Pimavanserin Reduces Relapse Risk in Patients With Dementia-Related Psychosis

Jessica Nye, PhD

Can the continuation of pimavanserin help with managing dementia-related psychosis? Researchers report on the findings of the phase 3 HARMONY trial.

Driving Habits May Help Identify Preclinical Alzheimer Disease

Heather R. Johnson

Investigators installed GPS data loggers with custom software in participants’ vehicles to see if driving performance could predict preclinical Alzheimer disease.